Learn how experts manage post-operative inflammation and pain following various ocular surgeries.
Marguerite McDonald, MD, FACS
Clinical professor of ophthalmology at NYU Langone Medical Center & Tulane University Health Sciences Center in New Orleans | OCLI Oceanside, New York
See Dr. Marguerite McDonald discuss the surgery and share her patient’s postoperative treatment with LOTEMAX® SM.
Related Content:Cataract Therapeutics
LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.
IMPORTANT SAFETY INFORMATION
Click here for full Prescribing Information for LOTEMAX® SM.
LOTEMAX is a trademark of Bausch & Lomb Incorporated or its affiliates.
© 2020 Bausch & Lomb Incorporated or its affiliates. LSM.0148.USA.20